HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perera, D. R. Articles by Schultz, M. G. Search for Related Content PubMed PubMed Citation Articles by Perera, D. R. Articles by Schultz, M. G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CLONITRALIDE NICLOSAMIDE QUINACRINE

Niclosamide^* Treatment of Cestodiasis

Clinical Trials in the United States

Niclosamide was given to 81 patients with tapeworm infection. Forty-seven patients received adequate follow-up, and 46 were cured; 17 of these had previously shown no improvement with quinacrine. Results indicate that niclosamide is a safe, simple, and effective agent against infection with Taenia saginata, Diphyllobothrium latum, and Hymenolepis nana.

Accepted for publication December 4, 1969.

^* Niclosamide (Yomesan) is available, for investigational use only, from the Parasitic Disease Drug Service, Parasitic Diseases Branch, Epidemiology Program, National Communicable Disease Center, Atlanta, Georgia 30333.

This article has been cited by other articles:

				R. D. PEARSON and E. L. HEWLETT Niclosamide Therapy for Tapeworm Infections Ann Intern Med, April 1, 1985; 102(4): 550 - 551. [Abstract] [PDF]

				R. H. JOHNSON and R. J. ELLIS Immunobiologic Agents and Drugs Available from the Center for Disease Control Ann Intern Med, July 1, 1974; 81(1): 61 - 67. [Abstract] [PDF]